Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features.

PURPOSE The central zone of the prostate gland is a region rarely associated with carcinoma. To our knowledge central zone tumors have not previously been compared to carcinoma originating in the peripheral or transition zone of the prostate gland. MATERIALS AND METHODS All 2,010 radical prostatectomy cases seen at our institution from October 1998 to December 2006 were reviewed to identify tumor zonal origin. Central zone carcinoma was characterized and compared with tumors of other zones. RESULTS Zonal origin was determined in a total of 2,494 tumors in 1,703 cases. Of the tumors 63 (2.5%) were of central zone origin with 59 of the 63 representing the index or main tumor. Comparative analysis of a defined subset of 726 cases showed that central zone cancers were significantly more aggressive than peripheral or transition zone cancers with a far greater risk of extracapsular extension, seminal vesicle invasion and positive surgical margins. Escape from the gland was often via the ejaculatory ducts and seminal vesicles. Kaplan-Meier analysis confirmed that the probability of post-prostatectomy biochemical failure was double that of tumors of the other zones with a far more rapid rate of failure. Multivariate Cox regression analysis identified Gleason grade, positive margins, extracapsular extension, tumor volume and preoperative serum prostate specific antigen as the major contributors to this poor prognosis, rather than specific zonal origin. CONCLUSIONS To our knowledge this study provides the first characterization and comparative analysis of central zone carcinoma, identifying these tumors as a rare but highly aggressive form of prostate carcinoma with a distinct route of spread from the gland that contrasts with tumors of other zones. Preoperative identification is currently hampered by the avoidance of biopsy targeting the central zone. However, if recognized preoperatively, aggressive intervention may possibly improve the currently bleak outlook.

[1]  T. Stamey,et al.  Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.

[2]  Hideaki Miyake,et al.  A comparison of the biological features between prostate cancers arising in the transition and peripheral zones , 2005, BJU international.

[3]  D. Hirschberg,et al.  Differential protein expression in anatomical zones of the prostate , 2005, Proteomics.

[4]  T. Schlomm,et al.  Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy. , 2007, European urology.

[5]  D. Johnston,et al.  Detailed mapping of prostate carcinoma foci , 2000, Cancer.

[6]  J. McNeal,et al.  Regional morphology and pathology of the prostate. , 1968, American journal of clinical pathology.

[7]  N. Tallada,et al.  An Immunohistochemical Study , 1992 .

[8]  Liang Cheng,et al.  Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens , 2005, Modern Pathology.

[9]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[10]  A. Freeman,et al.  Comparison of the zones of the human prostate with the seminal vesicle: Morphology, immunohistochemistry, and cell kinetics , 2005, The Prostate.

[11]  Hartwig Huland,et al.  Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy? , 2003, Urology.

[12]  A. Haese*,et al.  Transition zone cancers undermine the predictive accuracy of Partin table stage predictions. , 2005, The Journal of urology.

[13]  R. Cohen,et al.  Prediction of pathological stage and clinical outcome in prostate cancer: an improved pre-operative model incorporating biopsy-determined intraductal carcinoma. , 1998, British journal of urology.

[14]  M. Rubin,et al.  A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma. , 2007, Archives of pathology & laboratory medicine.

[15]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[16]  J. McNeal,et al.  Distribution of lactoferrin in the normal and inflamed human prostate: An immunohistochemical study , 1992, The Prostate.

[17]  G. Albertin,et al.  Gene expression and autoradiographic localization of endothelin-1 and its receptors A and B in the different zones of the normal human prostate. , 1997, The Journal of urology.

[18]  Patrick Royston,et al.  A new measure of prognostic separation in survival data , 2004, Statistics in medicine.

[19]  J. McNeal.  Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. , 1992, Human pathology.

[20]  J. McNeal,et al.  Normal histology of the prostate. , 1988, The American journal of surgical pathology.

[21]  J. Epstein,et al.  Central zone histology of the prostate: a mimicker of high-grade prostatic intraepithelial neoplasia. , 2002, Human pathology.

[22]  L. Sullivan,et al.  Transition zone carcinoma of the prostate. , 1995, The Canadian journal of urology.